Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cinthya Mendoza
Observed name:
Cinthya Zepeda Mendoza
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5115009602
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance
2024
·
Ayalew Tefferi
, Maymona Abdelmagid
, et al.
·
Blood
·
2
PDF
Progression of disease within 36 months (POD36) of starting first-line targeted therapy independently predicts poor overall survival in patients with chronic lymphocytic leukemia (CLL)
2025
·
Paul Hampel
, Kari Rabe
, et al.
·
Blood
·
1
17p loss in TP53-non-mutated myeloid neoplasms confers survival comparable to TP53-mutated disease
2025
·
Gunin Singhal
, Franceso Versino
, et al.
·
Blood
PDF
CSF3R-mutated chronic neutrophilic leukemia: A two-center study of 44 consecutive patients
2025
·
Abiola Bolarinwa
, Natasha Szuber
, et al.
·
Blood
PDF
Disease stage-specific mutational landscape in essential thrombocythemia and prognostic correlates: A Mayo Clinic study of 500 NGS-informative cases
2025
·
Merry Nakhleh
, Rong He
, et al.
·
Blood
PDF
Polycythemia Vera Vs. JAK2 Mutated or Wild-Type Essential Thrombocythemia: Clinical and Molecular Comparisons and Long-Term Outcome Among 2,010 Patients
2024
·
Giuseppe Gaetano Loscocco
, Moazah Iftikhar
, et al.
·
Blood
Show more works
View as search
Works count:
6
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
